enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - asztma - gyógyszerek obstruktív légúti betegségek, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - asztma - gyógyszerek obstruktív légúti betegségek, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - asztma - gyógyszerek obstruktív légúti betegségek, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - asztma - gyógyszerek obstruktív légúti betegségek, - maintenance treatment of asthma in adults whose disease is not adequately controlled.
elocom 0,1% krém
organon hungary kft. - expozíció -
nasonex 0,05% szuszpenziós adagolt orrspray
organon hungary kft. - expozíció -
momegen 1 mg/g kenőcs
viatris ltd. - expozíció -
omerid 1 mg/g kenőcs
glenmark europe ltd. - expozíció -
azocutan 1 mg/g krém
q pharma kft. - expozíció -
kalmente 50 mikrogramm/adag szuszpenziós orrspray
alvogen ipco s.ar.l. - mire furoate hidrát -